Investigating an implantable Vagus-nerve-stimulator device as a treatment for RA. Patient compensation available, no cost to you!
- Men and Women age 22-75 with moderate to severe rheumatoid arthritis
- Currently on a CsDMARD (methotrexate, hydroxychloroquine, Leflunomide, sulfasalazine)
- Inadequate or loss of response to a RA biologic
- Trial participation: 4 months – 3.8 years
If you are eligible and enroll, you will receive all study-related care at no cost. You will also receive monitoring by a research doctor.
For additional details or if you have questions, please call (425) 248-2635 or email firstname.lastname@example.org.
More info on this study: https://reset-ra.study